On October 6, the University of Washington and Johns Hopkins University hosted the symposium, “Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation.”
The symposium featured university experts and global leaders to discuss vaccine science, health metrics, policy, regulation and communications.
The keynote speakers
The keynote speakers included Francis Collins, MD, PhD, the director of the National Institutes of Health; Anthony Fauci, MD, the director of the National Institute of Allergy and Infectious Diseases; Peter Marks, MD, PhD, the director of the Center for Biologics Evaluation and Research at the U.S. Food and Drug Administration; and Moncef Slaoui, PhD, the chief advisor of Operation Warp Speed.
Other speakers included providers, researchers and leadership from both the University of Washington and Johns Hopkins University.
During the symposium, speakers discussed how to protect the scientific integrity of the COVID-19 vaccine development, with the ultimate goal being the equitable distribution of effective COVID-19 vaccines.
Topics spanned the ethics of the COVID-19 trials, essential elements of protecting scientific integrity, plans for how to ensure trials are inclusive and diverse, and more.
The symposium recording
To catch the entire discussion, watch the recording of the symposium below.